PureTech’s Vor Biopharma raises $42M for blood cancer drugs

Vor’s co-founder, who discovered the company's unique approach to fighting cancer, is Dr. Siddhartha Mukherjee, a Columbia University physician and author.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.